With CD40 being expressed on various B-cell lymphomas and carcinomas (nasopharynx, bladder, cervix, kidney and ovary), there is a renewed interest in CD40/CD40L in the control of tumor growth, leading to the development of new therapeutic strategies [51]. Here, CD40 is linked to B-cell non-Hodgkin lymphoma.